BR31: A phase 3, double blind, placebo controlled, randomised trial of adjuvant durvalumab in completely resected non-small cell lung cancer

被引：0
|
作者：
McLachlan, Sue-Anne [1 ,2 ]
Mersiades, Antony [3 ]
Wright, Gavin [4 ]
Millward, Michael [5 ]
Goss, Glenwood [6 ]
Darling, Gail [7 ,8 ]
Jurkovic, Hannora [3 ]
Bradley, Ann-Marie [9 ]
Pavlakis, Nick [10 ]
Blinman, Prunella [11 ,12 ]
Ding, Keyue [13 ]
O'Callaghan, Chris [9 ,14 ]
Stockler, Martin [3 ]
机构：
[1] St Vincents Hosp, Dept Med Oncol, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[4] St Vincents Hosp, Dept Surg, Melbourne, Vic, Australia
[5] Sir Charles Gairdner Hosp, Dept Med Oncol, Perth, WA, Australia
[6] Ottawa Hosp, Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada
[7] Toronto Gen Hosp, Univ Hlth Network, Div Thorac Surg, Dept Surg, Toronto, ON, Canada
[8] Univ Toronto, Toronto, ON, Canada
[9] Queens Univ, Canadian Canc Trials Grp, Kingston, ON, Canada
[10] Royal North Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia
[11] Concord Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia
[12] Univ Sydney, Sydney, NSW, Australia
[13] Queens Univ, Canc Res Inst, Canadian Canc Trials Grp, Kingston, ON, Canada
[14] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
419
引用
收藏
页码：198 / 199
页数：2
相关论文
共 50 条
  • [31] Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer
    Harubumi Kato
    Masahiro Tsuboi
    Yasufumi Kato
    Norihiko Ikeda
    Tetsuya Okunaka
    Chikuma Hamada
    International Journal of Clinical Oncology, 2005, 10 (3) : 157 - 164
  • [32] The Peninsula stage 3 non-small cell lung cancer audit: adjuvant durvalumab
    Smith, Philippa
    Bond, Hannah
    Weir, Eleanor
    Crook, Benjamin
    Fraser, Ian
    Ford, Victoria
    Phelps, Lyndsey
    Muse, Adam
    LUNG CANCER, 2023, 178 : S27 - S27
  • [33] Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE Trial
    Matsubara, Taichi
    Yamaguchi, Masafumi
    Shimokawa, Mototsugu
    Okamoto, Isamu
    CLINICAL LUNG CANCER, 2024, 25 (03) : 280 - 283
  • [34] Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer
    Nakagawa, K.
    Tada, H.
    Akashi, A.
    Yasumitsu, T.
    Iuchi, K.
    Taki, T.
    Kodama, K.
    BRITISH JOURNAL OF CANCER, 2006, 95 (07) : 817 - 821
  • [35] A Phase III Study of Adjuvant Chemotherapy in Patients with Completely Resected, Node-Negative Non-Small Cell Lung Cancer
    Kunitoh, H.
    Sakurai, H.
    Tsuboi, M.
    Wakabayashi, M.
    Okada, M.
    Suzuki, K.
    Ikeda, N.
    Takahama, M.
    Takenoyama, M.
    Ohde, Y.
    Yoshiya, K.
    Matsumoto, I.
    Yamashita, M.
    Marutsuka, T.
    Date, H.
    Hasumi, T.
    Yamashita, Y.
    Okumura, N.
    Watanabe, S.
    Asamura, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S270 - S271
  • [36] Phase II Trial of Adjuvant Chemotherapy with Bi-Weekly Carboplatin Plus Paclitaxel in Patients with Completely Resected Non-small Cell Lung Cancer
    Sugaya, Masakazu
    Uramoto, Hidetaka
    Uchiyama, Akihiko
    Nagashima, Akira
    Nakanishi, Ryoichi
    Sakata, Hisanobu
    Nakanishi, Kozo
    Hanagiri, Takeshi
    Yasumoto, Kosei
    ANTICANCER RESEARCH, 2010, 30 (07) : 3039 - 3044
  • [37] Adjuvant lung project Italy (ALPI): the Italian/EORTC-LCCG randomised trial of adjuvant cisplatin-based chemotherapy in completely resected non-small cell lung cancer (NSCLC)
    Scagliotti, G
    LUNG CANCER, 2004, 46 : S13 - S14
  • [38] A PHASE II TRIAL OF THE COMBINATION OF GEMCITABINE AND CARBOPLATIN AS ADJUVANT CHEMOTHERAPY IN PATIENTS WITH COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER. (KENBYO 0601)
    Muraoka, Masashi
    Akamine, Shinji
    Tsuchiya, Tomoshi
    Morino, Shigeyuki
    Kamohara, Ryotaro
    Mochinaga, Koji
    Shimoyama, Koichiro
    Sengyoku, Hideyori
    Obata, Tomohiro
    Mizoguchi, Satoshi
    Ikuta, Yasushi
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S581 - S581
  • [39] A phase III randomized, double-blind, placebo-controlled trial of the epidermal growth factor receptor inhibitor gefitinb in completely resected stage IB-IIIA non-small cell lung cancer (NSCLC): NCIC CTG BR.19
    Goss, G. D.
    Lorimer, I.
    Tsao, M. S.
    O'Callaghan, C. J.
    Ding, K.
    Masters, G. A.
    Roberts, P.
    Jett, J. R.
    Edelman, M. J.
    Shepherd, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
  • [40] PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer
    Antonia, S. J.
    Villegas, A.
    Daniel, D.
    Baz, D. Vincente
    Murakami, S.
    Hui, R.
    Yokoi, T.
    Chiappori, A.
    Lee, K. H.
    de Wit, M.
    Cho, B. C.
    Bourhaba, M.
    Quantin, X.
    Tokito, T.
    Mekhail, T.
    Planchard, D.
    Jiang, H.
    Huang, Y.
    Dennis, P. A.
    Ozguroglu, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (05): : 1314 - 1315
12345